Mechanisms of Visual Restoration After Occipital Stroke

Launched by UNIVERSITY OF ROCHESTER · Aug 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how the brain’s vision area recovers after a stroke that causes partial blindness. Specifically, researchers want to understand how damage to the part of the brain responsible for sight (called the visual cortex) affects vision, and how special visual training might help improve what’s left of a person’s vision. By using brain scans and vision tests, the study aims to learn more about how vision can be restored or improved after this kind of stroke.

People eligible for this study are adults between 21 and 80 years old who have a stroke or similar injury affecting one side of their primary visual cortex, leading to consistent vision loss in the same areas of both eyes. Participants must live in the U.S. or Canada, speak English well, have normal thinking and memory skills, and be able to use a computer with internet at home for training exercises. The study involves several days of testing and training in the lab, as well as doing visual training at home over a few months. Participants will also have MRI brain scans. People with other eye problems, brain injuries, or conditions that would interfere with the training or MRI scans are not eligible. This study is not yet recruiting but may be a good fit for those wanting to explore new ways to improve vision after an occipital stroke.

Gender

ALL

Eligibility criteria

• • Cortically Blind Subjects (n=50)
• Inclusion:
• • Subjects between 21 and 80 years of age
• • Subjects must be residents of the United States or Canada
• • Subjects must exhibit unilateral stroke or stroke-like damage to primary visual cortex or its immediate afferent white matter sustained within the specified age range of 21 - 80 years (verified by MRI and/or CT scans)
• • Subjects with reliable visual field defects in both eyes (homonymous defects) as measured by Humphrey, MAIA, Goldmann, and/or equivalent perimetry. This deficit must be large enough to enclose a 5-deg diameter visual stimulus.
• • Subjects must be able to fixate on visual targets reliably for 1000ms, with jitter over less than 1-deg of visual angle.
• • o Note: This will be initially assessed by review of visual field reports as supplied by subjects during the screening process. However, we will be unable to fully assess their fixation ability until they start the psychophysics testing in our lab. If at that time we discover that they are unable to maintain adequate fixation, they will be withdrawn from the study.
• • Subjects must be willing, able, and competent to provide their own informed consent
• • Subjects must have their own home computer (desktop or laptop) and reliable internet access
• • All subjects must have normal cognitive abilities and memory, sufficient to be able to understand and follow written and oral instructions in English, as well as to remember how to complete visual training at home, on their own, as instructed, for several months.
• • Justification: We can only accept English-speaking subjects due to a lack of resources for supporting those who would require interpreter services. As all of our subjects are required to spend 3-5 days in lab with rigorous testing and training requirements, we must be able to communicate clearly and with minimal misunderstandings. This would require for up to 5-full days of in person interpreter services, for which we do not have funding. Additionally, ongoing communications take place by phone, email, and/or text as a part of home training (for routine check-ins and technical support for example) in the intervals between laboratory visits. This would require us to essentially have "on demand" access to interpreter services, which is simply not feasible.
• • Subjects must be safe and willing to undergo magnetic resonance imaging (MRI) scans
• Exclusion:
• • Subjects who have past or present ocular disease interfering with visual acuity
• • Subjects with best-corrected visual acuity (BCVA) worse than 20/40 in either eye
• • Subjects who have documented or suspected damage to the dorsal Lateral Geniculate Nucleus
• • Subjects who have diffuse whole-brain degenerative processes
• • Subjects who have experienced traumatic brain injury
• • Subjects who have any other brain damage deemed by study staff to potentially interfere with training ability or outcome measures
• • Subjects who have oculomotor defects deemed by study staff to potentially interfere with training ability or outcome measures (i.e., by impairing stable fixation during testing or training)
• • Subjects who have documented history of drug/alcohol abuse
• • Subjects who are currently taking neuroactive medications which would impact training, as determined by PI
• • Subjects who have cognitive, memory or seizure disorders
• • Subjects with one-sided attentional neglect
• • Subjects who lack the competence or are otherwise unable to perform the visual training exercises as directed.
• • Subjects who have contradictions to MRI scanning will be excluded. These contraindications include: a) central nervous system aneurysm clips; b) implanted neural stimulator; c) implanted cardiac pacemaker or defibrillator; d) cochlear implant; e) ocular foreign body (e.g., metal shavings); f) insulin pump; g) metal shrapnel or bullet; h) any implanted device that is incompatible with MRI.
• • Subjects who have conditions that preclude MRI scanning, e.g., morbid obesity, claustrophobia.